Literature DB >> 3197813

The fibroblast-like nature of myofibroblasts.

D Oda1, A M Gown, J S Vande Berg, R Stern.   

Abstract

The myofibroblast is found in normal tissue as well as in a wide variety of pathological processes. We have cultured myofibroblasts and dermal fibroblasts and have found that they secrete similar type-specific procollagens into the culture media. These were primarily type I and III procollagens with a predominance of type I procollagen. These patterns are distinctly different from those of smooth muscle cells, which synthesize predominantly type III procollagen. Cultured fixed cells were also examined by immunohistochemistry. Both myofibroblasts and fibroblasts stained positively with antibodies to type I and III procollagens. Reaction to type V procollagen antibodies was prominent only in the myofibroblast, as was immunostaining with anti-muscle actin antibodies. Immunostaining with desmin antibodies was negative in both cell types. By electron microscopy, the myofibroblast had well-developed dense microfilament fibers of 40-80 degrees that were prominent in the long axes of the cells near the cellular margins. Although the myofibroblast has properties of both smooth muscle cells and fibroblasts, it appears to be most likely a modified fibroblast that has undergone differentiation, probably in response to specific signals from the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197813     DOI: 10.1016/0014-4800(88)90004-4

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  14 in total

1.  Technology and uses of cell cultures from the tissues and organs of bony fish.

Authors:  N C Bols; L E Lee
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

2.  Selective location of palisaded myofibroblastoma with amianthoid fibres.

Authors:  G Bigotti; A Coli; M Mottolese; F Di Filippo
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

3.  Helium-neon laser treatment transforms fibroblasts into myofibroblasts.

Authors:  N Pourreau-Schneider; A Ahmed; M Soudry; J Jacquemier; F Kopp; J C Franquin; P M Martin
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

4.  Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture.

Authors:  L Rønnov-Jessen; B Van Deurs; M Nielsen; O W Petersen
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

5.  Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds.

Authors:  G F Pierce; J Vande Berg; R Rudolph; J Tarpley; T A Mustoe
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

6.  Crimp frequency is strongly correlated to myofibroblast density in the human anterior cruciate ligament and its autologous tendon grafts.

Authors:  Markus Weiss; Frank N Unterhauser; Andreas Weiler
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-31       Impact factor: 4.342

7.  Collagen secretion granules in reactive stromal myofibroblasts, with preliminary observations on their occurrence in spindle cell tumours.

Authors:  B P Eyden
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration.

Authors:  Hidekata Yasuoka; Zhihong Zhou; Joseph M Pilewski; Tim D Oury; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Morphological identification of and collagen synthesis by periacinar fibroblastoid cells cultured from isolated rat pancreatic acini.

Authors:  Y Kato; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

10.  TGF-beta1 induces human bronchial epithelial cell-to-mesenchymal transition in vitro.

Authors:  Min Zhang; Zhi Zhang; Hai-Yan Pan; De-Xi Wang; Zhe-Tong Deng; Xiao-Ling Ye
Journal:  Lung       Date:  2009-02-28       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.